May 2024 Financial News

Agostini's Limited - Notice of Material Change - Appointment of Chief Transformation Officer - Pharmaceutical Group

May 20, 2024

Notice of Appointment
Chief Transformation Officer - Pharmaceutical Group

Agostini’s Limited is pleased to announce the appointment of Ms. Donnia Sooklal to the position of Chief Transformation Officer – Pharmaceutical Group, effective May 20th, 2024.

Ms. Sooklal brings with her over twenty years’ experience specializing in transforming Life Sciences businesses in the US. She held key consulting roles at EY, BCG and Deloitte, where she drove healthcare innovation and enhanced operational performance for leading pharmaceutical companies. Her industry experience includes managing cardiovascular and metabolic disease clinical trials and technology investments at Pfizer, and most recently, managing the commercialization of oncology drugs as Director of Strategic Planning and Execution at Boehringer Ingelheim.

Ms. Sooklal holds a Master of Business Administration from Cornell University and a Bachelor of Science in Management Studies from the University of the West Indies.

 

Source:
The Trinidad and Tobago Stock Exchange Limited
Monday 20th May, 2024